Details of the Drug Combinations

General Information of This Drug (ID: DM7245Q)

Drug Name

Ioxaglate DM7245Q

Synonyms

ioxaglic acid; Ioxaglate; Hexabrix 160; 59017-64-0; Acido ioxaglico; Acide ioxaglique; Acidum ioxaglicum; UNII-Z40X7EI2AF; P 286 (Contrast medium); Acido ioxaglico [INN-Spanish]; Acidum ioxaglicum [INN-Latin]; Acide ioxaglique [INN-French]; EINECS 261-560-1; Z40X7EI2AF; N-(2-Hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(N-methylacetamido)-5-(methylcarbamoyl)benzamido)acetamido)isophthalamic acid; P 286; CHEBI:31718

Indication

Disease Entry	ICD 11	Status	REF
Cardiovascular disease	BA00-BE2Z	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Ioxaglate + Bivalirudin	DCQUIF6	Bivalirudin	Coronary Artery Disease	[2]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	ClinicalTrials.gov (NCT01848899) Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography